Santiappillai, N.T.; Abuhammad, S.; Slater, A.; Kirby, L.; McArthur, G.A.; Sheppard, K.E.; Smith, L.K.
CDK4/6 Inhibition Reprograms Mitochondrial Metabolism in BRAFV600 Melanoma via a p53 Dependent Pathway. Cancers 2021, 13, 524.
https://doi.org/10.3390/cancers13030524
AMA Style
Santiappillai NT, Abuhammad S, Slater A, Kirby L, McArthur GA, Sheppard KE, Smith LK.
CDK4/6 Inhibition Reprograms Mitochondrial Metabolism in BRAFV600 Melanoma via a p53 Dependent Pathway. Cancers. 2021; 13(3):524.
https://doi.org/10.3390/cancers13030524
Chicago/Turabian Style
Santiappillai, Nancy T., Shatha Abuhammad, Alison Slater, Laura Kirby, Grant A. McArthur, Karen E. Sheppard, and Lorey K. Smith.
2021. "CDK4/6 Inhibition Reprograms Mitochondrial Metabolism in BRAFV600 Melanoma via a p53 Dependent Pathway" Cancers 13, no. 3: 524.
https://doi.org/10.3390/cancers13030524
APA Style
Santiappillai, N. T., Abuhammad, S., Slater, A., Kirby, L., McArthur, G. A., Sheppard, K. E., & Smith, L. K.
(2021). CDK4/6 Inhibition Reprograms Mitochondrial Metabolism in BRAFV600 Melanoma via a p53 Dependent Pathway. Cancers, 13(3), 524.
https://doi.org/10.3390/cancers13030524